| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |